Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Sutton

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1994
Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in ratsD O Scott, D S Bindra, S C Sutton, et al.
Pharmaceutical Research|October 1, 1996
Predicting injection site muscle damage. II: Evaluation of extended release parenteral formulations in animal modelsS C Sutton, L A Evans, M T Rinaldi, et al.
Pharmaceutical Research|October 1, 1996
Predicting injection site muscle damage. I: Evaluation of immediate release parenteral formulations in animal modelsS C Sutton, L A Evans, M T Rinaldi, et al.
Pharmaceutical Research|October 1, 1996
Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell modelL A Evans, P E Genereux, E M Gibbs, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 15, 2012
Estimating product bioequivalence for highly variable veterinary drugsR Claxton, J Cook, L Endrenyi, et al.
Pharmaceutical Research|March 1, 1992
Simultaneous in vitro measurement of intestinal tissue permeability and transepithelial electrical resistance (TEER) using Sweetana-Grass diffusion cellsS C Sutton, A E Forbes, R Cargill, et al.
Pharmaceutical Research|October 1, 1993
Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dogS C Sutton, E L LeCluyse, K Engle, et al.
Pharmaceutical Research|August 1, 1990
Performance of diltiazem tablet and multiparticulate osmotic formulations in the dogS C Sutton, K Engle, R A Deeken, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 20, 2003
Osmotic drug delivery using swellable-core technologyA G Thombre, L E Appel, M B Chidlaw, et al.
Pharmaceutical Research|November 1, 1993
Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humansH Cheng, S C Sutton, J D Pipkin, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1994
Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in ratsD O Scott, D S Bindra, S C Sutton, et al.
Pharmaceutical Research|October 1, 1996
Predicting injection site muscle damage. II: Evaluation of extended release parenteral formulations in animal modelsS C Sutton, L A Evans, M T Rinaldi, et al.
Pharmaceutical Research|October 1, 1996
Predicting injection site muscle damage. I: Evaluation of immediate release parenteral formulations in animal modelsS C Sutton, L A Evans, M T Rinaldi, et al.
Pharmaceutical Research|October 1, 1996
Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell modelL A Evans, P E Genereux, E M Gibbs, et al.
Journal of Veterinary Pharmacology and Therapeutics|March 15, 2012
Estimating product bioequivalence for highly variable veterinary drugsR Claxton, J Cook, L Endrenyi, et al.
Pharmaceutical Research|March 1, 1992
Simultaneous in vitro measurement of intestinal tissue permeability and transepithelial electrical resistance (TEER) using Sweetana-Grass diffusion cellsS C Sutton, A E Forbes, R Cargill, et al.
Pharmaceutical Research|October 1, 1993
Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dogS C Sutton, E L LeCluyse, K Engle, et al.
Pharmaceutical Research|August 1, 1990
Performance of diltiazem tablet and multiparticulate osmotic formulations in the dogS C Sutton, K Engle, R A Deeken, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 20, 2003
Osmotic drug delivery using swellable-core technologyA G Thombre, L E Appel, M B Chidlaw, et al.
Pharmaceutical Research|November 1, 1993
Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humansH Cheng, S C Sutton, J D Pipkin, et al.
Pageof 2